There’s a lot you can do to help your child with lupus. Learning as much as you can about the disease is an important first step. In this program we will cover tools and resources to help a parent ...

Since lupus can cause problems anywhere in the body, your child may need to see different types of pediatricians (doctors who provide care to children from birth to young adulthood) and health care ...

FORT WORTH, Texas -- Childhood-onset systemic lupus erythematosus (SLE) differs from adult-onset disease in important ways, but treatment approaches generally have derived from the adult arena, a ...

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune rheumatic disease. Although its highest prevalence is among women of childbearing age, the disease is not confined within this ...

The U.S. Food and Drug Administration has given Seattle Children’s the green light to conduct a clinical trial for a drug that researchers hope can help fight pediatric lupus. The drug known as ...

The 200mg single-dose prefilled autoinjector allows pediatric patients to receive LN treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab), ...

In a cross-sectional study, insulin growth factor binding protein 2 (IFGBP-2) showed promise as a prognosis biomarker for renal disease in pediatric lupus nephritis (LN). Serum insulin growth factor ...

DENVER — Neuropsychiatric lupus is “arguably the least understood manifestation” of systemic lupus erythematosus (SLE) in children, with patients facing substantial barriers and experiencing highly ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who ...

The FDA has expanded the approval of belimumab to include pediatric patients 5 to 17 years of age with active lupus nephritis. The Food and Drug Administration (FDA) has expanded the approval of ...

Please provide your email address to receive an email when new articles are posted on . The award provides $3 million to develop novel techniques to treat kidney disease. The project uses imaging ...

The Food and Drug Administration (FDA) has expanded the approval of Benlysta (belimumab) to include pediatric patients 5 to 17 years of age with active lupus nephritis who are receiving standard ...